NCT05672303

Brief Summary

Many painful interventions that cause pain and stress are applied to preterm babies in the neonatal intensive care unit for diagnosis and treatment. In neonatal care and reduction of acute interventional pain; Non-pharmacological methods including behavioral, psychological and environmental regulations should be used. In the hepatitis B vaccine administered to preterm babies, stimulating the grasping reflex can make the preterm baby feel safe and calm. In the literature, there are many studies aimed at reducing pain in preterm newborns. However, no study has been found on the effect of grasping reflex stimulation on pain and crying in hepatitis B vaccine administration to preterm infants. This study was planned to examine the effect of grasping reflex on pain and crying duration in preterm infants with hepatitis B vaccine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 3, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 5, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2023

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

May 28, 2024

Status Verified

May 1, 2024

Enrollment Period

5 months

First QC Date

January 3, 2023

Last Update Submit

May 24, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • pain level will be measured in the premature baby

    PIPP-R Form: The PIPP scale, developed by Stevens et al. in 1996, is a validated assessment tool used to evaluate acute pain experienced by preterm infants during interventional procedures (Stevens et al., 1996). This scale was revised by Stevens et al. in 2014 (Stevens et al., 2014). The PIPP-R was adapted into Turkish in 2019 (Taplak, \& Bayat, 2019). PIPP-R consists of behavioral subscales such as frowning, squeezing eyes, nasolabial furrow, physiological and behavioral status including heart rate and SPO2, and contextual subscales such as gestational age.

    15 minutes

Secondary Outcomes (1)

  • Crying time

    15 minutes

Study Arms (2)

Control

NO INTERVENTION

Routine procedure will be applied

Experimental

EXPERIMENTAL

Palmar grasp reflex will be stimulated with routine procedure.

Behavioral: Palmar grasp reflex

Interventions

The reflex can be stimulated by moving an object distally across the palm. In the study, at the beginning of the vaccine administration, the right hand of the infant will be moved distally along the palm with the researcher's index finger, thus providing reflex stimulation.

Experimental

Eligibility Criteria

Age28 Weeks - 36 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • gestational week
  • No congenital malformation
  • follow up with a diagnosis of respiratory distress syndrome,
  • receive oxygen support with a nasal cannula or tube,
  • not receive mechanical ventilation support,
  • no contraindications for hepatitis B vaccine administration,
  • stable vital signs before vaccination,
  • not receive analgesic sedation treatment
  • whose parents give verbal and written consent to participate in the study.

You may not qualify if:

  • Infants of parents who did not give informed voluntary consent will not be included in the study.
  • Decreased oxygen saturation levels
  • Tachycardia just before the vaccine administration
  • Invasive intervention in the right hand.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Türkan Kadiroğlu

Yakutiye, Erzurum, 25040, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pricipal Investigator

Study Record Dates

First Submitted

January 3, 2023

First Posted

January 5, 2023

Study Start

November 1, 2022

Primary Completion

March 30, 2023

Study Completion

April 1, 2023

Last Updated

May 28, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations